Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Annals of hematology. - 102, 1 (2023) , 245-247, ISSN: 1432-0584
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2022
- Creator
- DOI
-
10.1007/s00277-022-05035-y
- URN
-
urn:nbn:de:bsz:25-freidok-2312013
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Time of origin
- 2022
Other Objects (12)
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
15-year remission in refractory FLT3-mutated AML attained by sorafenib
15-year remission in refractory FLT3-mutated AML attained by sorafenib
Allogeneic stem cell transplantation in multiple myeloma
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
15-year remission in refractory FLT3-mutated AML attained by sorafenib
15-year remission in refractory FLT3-mutated AML attained by sorafenib
Allogeneic stem cell transplantation in multiple myeloma
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
15-year remission in refractory FLT3-mutated AML attained by sorafenib
15-year remission in refractory FLT3-mutated AML attained by sorafenib
Allogeneic stem cell transplantation in multiple myeloma
Molekulare Mechanismen der Entstehung von B-Zell-Lymphomen des Menschen
Ein solid-phase-Radioimmunoassay zum Nachweis des Epstein-Barr-Virus-assoziierten Frühantigen-Komplexes (Early Antigen)
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life